Research and Development

Showing 15 posts of 9615 posts found.

Sanofi diabetes drug Sulinqua green-lighted in Europe

January 19, 2017 Research and Development, Sales and Marketing Sanofi, Sulinqua

Sanofi’s diabetes drug Suliqua has been granted marketing authorisation by the European Commission, giving the go ahead for the launch …
shutterstock_159488225

Alcobra axes ADHD drug after Phase 3 failure

January 18, 2017 Research and Development ADHD, Alcobra, metadoxine

Israeli-based firm Alcobra is to pull the plug on its experimental attention deficit hyperactivity disorder (ADHD) drug metadoxine after it …
biogen_austria_238

Biogen shells out $1.25bn to protect best-selling MS drug

January 18, 2017 Research and Development, Sales and Marketing Biogen, Forward Pharma, multiple sclerosis, tecfidera

Biogen has announced it is to pay $1.25 billion to Copenhagen-based biotech Forward Pharma in the latest development in a …
bribe

Researchers financed by pharma more likely to produce positive results, new report says

January 18, 2017 Research and Development clinical trials

A new paper published in the British Medical Journal (BMJ) has called the integrity of certain clinical trials into question …
access_accelerated

22 pharma companies join forces for global non-communicable disease initiative

January 18, 2017 Research and Development BMS, Celgene, Eisai, Eli Lilly, GSK, J&J, JJ, MSD, Merck, Novartis, Pfizer, Roche, Sanofi, Takeda

The World Economic Forum Annual Meeting in Switzerland has seen the launch of Access Accelerated, a global initiative consisting of …
theresa_may

PM May announces Brexit plan, BioIndustry Association CEO reacts

January 18, 2017 Research and Development, Sales and Marketing Theresa May, brexit

After months of uncertainty following the UK’s vote to leave the EU, Theresa May has finally announced the first inklings …
shutterstock_206748499

Centre for Process Innovation to support pharma SMEs

January 17, 2017 Manufacturing and Production, Medical Communications, Research and Development CPI, Centre for Process Innovation

The Centre for Process Innovation is targeting small and medium-sized enterprises from the pharmaceutical and chemical industries with its Innovation …
mr058666-web

Merck forges data analytics partnership with Palantir

January 17, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Merck, Palantir

Merck has teamed up with software and data-mining firm Palantir with the intention to utilise its data analytics services to …

AZ to rework ongoing immuno-oncology trials to “enhance options”

January 17, 2017 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, non-small cell lung cancer

Due to the “strong efficacy” shown by its durvalumab as a treatment for non-small cell lung cancer (NSCLC), AstraZeneca has …
researchers_credit_neusentis_pfizer

Benzodiazepines increase stroke risk in Alzheimer’s patients, study finds

January 16, 2017 Research and Development, Sales and Marketing Alzheimer's, Alzheimers, benzodiazepines

Benzodiazepines and similar drugs could increase the risk of strokes in Alzheimer’s patients by as much as 20% according to …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

We’re now into 2017 in earnest and news of acquisitions, partnerships, R&D advancements and scandals are back in force. Cancer …

IBM and FDA collaborate to protect patient data with blockchain technology

January 12, 2017 Medical Communications, Research and Development FDA, blockchain, blockchain technology, ibm

IBM Watson Health has agreed a research initiative with the FDA to develop and test the exchange of patients’ health …
entrance_takeda_i020_v1

Takeda invests $125m in Maverick T-cell platform partnership

January 12, 2017 Research and Development Maverick, Takeda

Takeda has announced its intention to invest $125 million in a partnership with Maverick Therapeutics to develop the latter’s T-cell …
shire_image_4

Shire fined $350 million in largest-ever bribery case of its kind

January 12, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire. Department of Justice

Shire Pharmaceuticals is set to pay a $350 million settlement over accusations that it had bribed clinicians and physicians by …

New immunotherapy-based cancer research limits cancer spread by 75%

January 12, 2017 Medical Communications, Research and Development Cancer, cancer research, immunotherapy

Research conducted by the Sanger Institute in Cambridge has discovered 23 new genes associated with cancer cell’s spread through the …
The Gateway to Local Adoption Series

Latest content